Fund profile
Tickers
FBT
Fund manager
Total assets
$1.28 bn
Liabilities
$16.73 mm
Net assets
$1.26 bn
Number of holdings
32.00
FBT stock data
32 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
SRPT Sarepta Therapeutics Inc | 51.84 mm | 427.66 k shares | 4.12 | Common equity | Long | USA |
AMGN AMGEN Inc. | 51.82 mm | 192.81 k shares | 4.12 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 51.56 mm | 458.30 k shares | 4.10 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 50.72 mm | 61.63 k shares | 4.03 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals Inc | 50.52 mm | 1.11 mm shares | 4.01 | Common equity | Long | USA |
EXEL Exelixis Inc | 50.24 mm | 2.30 mm shares | 3.99 | Common equity | Long | USA |
SGEN Seagen Inc. | 49.35 mm | 232.60 k shares | 3.92 | Common equity | Long | USA |
BMRN Biomarin Pharmaceutical Inc. - Registered Shares | 45.67 mm | 516.14 k shares | 3.63 | Common equity | Long | USA |
BNTX BioNTech SE | 45.30 mm | 416.94 k shares | 3.60 | Common equity | Long | Germany |
VRTX Vertex Pharmaceuticals, Inc. | 43.44 mm | 124.91 k shares | 3.45 | Common equity | Long | USA |
CRL Charles River Laboratories International Inc. | 42.99 mm | 219.38 k shares | 3.42 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 42.08 mm | 561.46 k shares | 3.34 | Common equity | Long | USA |
BIIB Biogen Inc | 42.05 mm | 163.61 k shares | 3.34 | Common equity | Long | USA |
UTHR United Therapeutics Corp | 41.20 mm | 182.39 k shares | 3.27 | Common equity | Long | USA |
INCY Incyte Corp. | 40.77 mm | 705.78 k shares | 3.24 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals Inc | 40.72 mm | 1.65 mm shares | 3.24 | Common equity | Long | USA |
ARGX Argen X SE | 40.59 mm | 82.56 k shares | 3.22 | Common equity | Long | Netherlands |
ALNY Alnylam Pharmaceuticals Inc | 40.08 mm | 226.30 k shares | 3.18 | Common equity | Long | USA |
Grifols SA
|
39.83 mm | 4.36 mm shares | 3.16 | Common equity | Long | Spain |
ALKS Alkermes plc | 39.73 mm | 1.42 mm shares | 3.16 | Common equity | Long | Ireland |
QGEN Qiagen NV | 39.32 mm | 970.96 k shares | 3.12 | Common equity | Long | Netherlands |
IQV IQVIA Holdings Inc | 39.03 mm | 198.35 k shares | 3.10 | Common equity | Long | USA |
GMAB Genmab | 38.40 mm | 1.09 mm shares | 3.05 | Common equity | Long | Denmark |
RARE Ultragenyx Pharmaceutical Inc. | 37.36 mm | 1.05 mm shares | 2.97 | Common equity | Long | USA |
MRNA Moderna Inc | 36.99 mm | 358.11 k shares | 2.94 | Common equity | Long | USA |
MTD Mettler-Toledo International, Inc. | 36.84 mm | 33.25 k shares | 2.93 | Common equity | Long | USA |
TECH Bio-Techne Corp | 34.47 mm | 506.33 k shares | 2.74 | Common equity | Long | USA |
ILMN Illumina Inc | 32.63 mm | 237.68 k shares | 2.59 | Common equity | Long | USA |
EXAS Exact Sciences Corp. | 32.50 mm | 476.44 k shares | 2.58 | Common equity | Long | USA |
ACAD Acadia Pharmaceuticals Inc | 30.63 mm | 1.47 mm shares | 2.43 | Common equity | Long | USA |
BNP Paribas Securities Corp | 11.57 mm | 11.57 mm principal | 0.92 | Repurchase agreement | Long | USA |
Goldman Sachs Financial Square Treasury Obligations Fund | 3.93 mm | 3.93 mm shares | 0.31 | Short-term investment vehicle | Long | USA |